Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Jasbir Seehra, PhD$2.1B
Market Cap • 18/04/20242015
(há 9 anos)
2020
(4 years ago)
NASDAQ
Listagem
Lexington
Sede • Massachusetts105
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
KROSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.